← Eichor
Study identifier: NCT03373721 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Gut Microbiota of Preterm Infants and Full-term Infants at Early Life

Condition: Preterm Infant · Gut Microbiome  ·  Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

PhaseN/A
Planned participants102
Who can joinAll sexes, 1 Day to 4 Months
Healthy volunteersYes

About this study

The aim of this study is to obtain a longitudinal view of the gut microbial establishment of a cohort of 51 preterm (PT) infants compared to 50 full-term (FT) infants from birth to 90 days of age, and to identify key clinical factors that affect the establishment of neonatal microbiome. The hypothesis of the investigators is that the gut microbiota progression of PT group and FT group is different in diversity and composition. Antibiotics and its usage duration is likely the main factor disturbing the colonization and development of the gut microbiome of PT infants.

This description comes directly from the study's public registry record.

Talk to the study team

Jie Jia, PhD  ·  0086-13122322289  ·  jie.jia@shsmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Department of NICU, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of MedicineShanghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03373721